BOS 0.00% 1.5¢ biosignal limited

dental breakthrough, page-16

  1. 4,460 Posts.
    Its all potential for now but it has widespead applications and other results due shortly, the dental area is just another big plus and market. Unlike recaldent which took time to develop and is only for teeth. BOS products appear to have multi uses if you look into the company. Buy on weakness for RON. :)
 
watchlist Created with Sketch. Add BOS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.